Please login to the form below

Oncodesign

This page shows the latest Oncodesign news and features for those working in and with pharma, biotech and healthcare.

Deal Watch January 2016

Staying with oncology, BMS has entered a collaboration with Oncodesign for the development and commercialisation of novel macrocyclin compounds. ... Oncodesign will receive a $3m upfront and will undertake to lead optimisation work with BMS taking over
Pharma deals during September 2012

Baxter has an existing equity investment of $50m in Onconova. In a couple of earlier stage deals, Sanofi and Oncodesign have entered into a research collaboration and licence agreement to use ... The Nanocyclix platform will be exclusively applied in

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Add my company

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

2019: CRISPR and therapeutic gene editing comes of age: Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge: Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis: Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....